Sodium valproate CR (200mg')'''
Sep 06, 2023
Sodium valproate CR (controlled release)
VALPOTREAT CR is a formulation of the medication sodium valproate. Sodium valproate is a prescription medication used primarily to treat epilepsy and bipolar disorder. The CR formulation is designed to release the medication slowly over an extended period, providing a more consistent blood concentration of the drug.
VALPOTREAT CR is classified as an anticonvulsant and mood stabilizer. VALPOTREAT CR works by increasing the levels of gamma-aminobutyric acid (GABA), a neurotransmitter that helps calm down overactive electrical signals in the brain. This helps reduce seizures in epilepsy and stabilize mood in bipolar disorder.
The controlled-release formulation of VALPOTREAT CR is typically prescribed to help maintain steady therapeutic levels of the medication in the bloodstream. This can lead to better seizure control and mood stabilization for individuals taking the medication.
For further information please contact:
info@sterispharma.com
order now: - https://www.sterisonline.com/product/valpotreat-cr-200-134218
Recent Post

SOLIFENAC 10: Effective Relief for Overactive Bladder.

PIDOMIDE 400: Strengthening Immunity with Pidotimod 400mg Tablet.

LYMECYCLE 408: A Reliable Antibiotic for Bacterial Infections.

LONICAZOLE PLUS 20: An Advanced Topical Solution for Skin Conditions.

APIXAZEN 2.5mg: A Reliable Anticoagulant for Blood Clot Prevention

PRAZIQUNA PLUS 600mg: An Effective Solution for Parasitic Infections.

Paracetamol IP 500 mg, Phenylephrine Hydrochloride IP 5 mg, Caffeine IP 30 mg, Diphenhydramine Hydrochloride IP 25 mg

Empagliflozin and Metformin Hydrochloride Prolonged Release 5 mg/500 mg Tablet.

Metformin Hydrochloride Extended Release 1000 mg Tablets: Gliempaflozin Tablet.

empagliflozin 25mg+ metformin hydrochloride (extended release) 1000 mg